BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 16940890)

  • 21. [Metabolic characteristics and associated factors of nonalcoholic fatty liver disease diagnosed at medical checkups].
    Nah EH; Park JY
    Korean J Lab Med; 2008 Jun; 28(3):244-50. PubMed ID: 18594178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiological, clinical, and biochemical characteristics of Saudi patients with nonalcoholic fatty liver disease: a hospital-based study.
    Al-hamoudi W; El-Sabbah M; Ali S; Altuwaijri M; Bedewi M; Adam M; Alhammad A; Sanai F; Alswat K; Abdo A
    Ann Saudi Med; 2012; 32(3):288-92. PubMed ID: 22588441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study.
    Eguchi Y; Hyogo H; Ono M; Mizuta T; Ono N; Fujimoto K; Chayama K; Saibara T;
    J Gastroenterol; 2012 May; 47(5):586-95. PubMed ID: 22328022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics.
    Riquelme A; Arrese M; Soza A; Morales A; Baudrand R; Pérez-Ayuso RM; González R; Alvarez M; Hernández V; García-Zattera MJ; Otarola F; Medina B; Rigotti A; Miquel JF; Marshall G; Nervi F
    Liver Int; 2009 Jan; 29(1):82-8. PubMed ID: 18647235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant correlations between severe fatty liver and risk factors for metabolic syndrome.
    Hsiao PJ; Kuo KK; Shin SJ; Yang YH; Lin WY; Yang JF; Chiu CC; Chuang WL; Tsai TR; Yu ML
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2118-23. PubMed ID: 18031368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile.
    Quirós-Tejeira RE; Rivera CA; Ziba TT; Mehta N; Smith CW; Butte NF
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):228-36. PubMed ID: 17255837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases.
    Angelico F; Del Ben M; Conti R; Francioso S; Feole K; Maccioni D; Antonini TM; Alessandri C
    J Gastroenterol Hepatol; 2003 May; 18(5):588-94. PubMed ID: 12702052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.
    Fan JG; Li F; Cai XB; Peng YD; Ao QH; Gao Y
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1086-91. PubMed ID: 17608855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia.
    Chan WK; Tan AT; Vethakkan SR; Tah PC; Vijayananthan A; Goh KL
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1375-83. PubMed ID: 23517307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase.
    López-Suárez A; Guerrero JM; Elvira-González J; Beltrán-Robles M; Cañas-Hormigo F; Bascuñana-Quirell A
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1011-7. PubMed ID: 21915061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
    Prokopowicz Z; Malecka-Tendera E; Matusik P
    Can J Gastroenterol Hepatol; 2018; 2018():9465784. PubMed ID: 29854716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A community-based epidemiological study of elevated serum alanine aminotransferase levels in Kinmen, Taiwan.
    Liu CM; Tung TH; Liu JH; Chen VT; Lin CH; Hsu CT; Chou P
    World J Gastroenterol; 2005 Mar; 11(11):1616-22. PubMed ID: 15786537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus.
    Leite NC; Salles GF; Araujo AL; Villela-Nogueira CA; Cardoso CR
    Liver Int; 2009 Jan; 29(1):113-9. PubMed ID: 18384521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study.
    Xu C; Yu C; Ma H; Xu L; Miao M; Li Y
    Am J Gastroenterol; 2013 Aug; 108(8):1299-304. PubMed ID: 23567356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
    Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
    Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and risk factors of nonalcoholic fatty liver disease in a general population, the HUNT study.
    Bjørnå ER; Engelsen MT; El-Serag HB; Ness-Jensen E
    Scand J Gastroenterol; 2023 May; 58(5):505-511. PubMed ID: 36314512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
    Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of characteristics between nonobese and overweight/obese subjects with nonalcoholic fatty liver disease in a South Indian population.
    Vendhan R; Amutha A; Anjana RM; Unnikrishnan R; Deepa M; Mohan V
    Diabetes Technol Ther; 2014 Jan; 16(1):48-55. PubMed ID: 24028151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.